Amer Bio Medica
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rap… Read more
Amer Bio Medica (ABMC) - Total Assets
Latest total assets as of March 2023: $659.00K USD
Based on the latest financial reports, Amer Bio Medica (ABMC) holds total assets worth $659.00K USD as of March 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Amer Bio Medica - Total Assets Trend (1996–2022)
This chart illustrates how Amer Bio Medica’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Amer Bio Medica - Asset Composition Analysis
Current Asset Composition (December 2022)
Amer Bio Medica's total assets of $659.00K consist of 60.6% current assets and 39.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.7% |
| Accounts Receivable | $284.00K | 22.4% |
| Inventory | $379.00K | 29.9% |
| Property, Plant & Equipment | $479.00K | 37.8% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1996–2022)
This chart illustrates how Amer Bio Medica's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Amer Bio Medica's current assets represent 60.6% of total assets in 2022, a decrease from 95.7% in 1996.
- Cash Position: Cash and equivalents constituted 2.7% of total assets in 2022, down from 42.9% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 1996.
- Asset Diversification: The largest asset category is property, plant & equipment at 37.8% of total assets.
Amer Bio Medica Competitors by Total Assets
Key competitors of Amer Bio Medica based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Amer Bio Medica - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Amer Bio Medica generates 0.72x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Amer Bio Medica is currently not profitable relative to its asset base.
Amer Bio Medica - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.59 | 0.36 | 1.05 |
| Quick Ratio | 0.50 | 0.22 | 0.35 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-458.00K | $ -1.83 Million | $ 90.00K |
Amer Bio Medica - Advanced Valuation Insights
This section examines the relationship between Amer Bio Medica's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -32.6% |
| Total Assets | $1.27 Million |
| Market Capitalization | $3.55K USD |
Valuation Analysis
Below Book Valuation: The market values Amer Bio Medica's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Amer Bio Medica's assets decreased by 32.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Amer Bio Medica (1996–2022)
The table below shows the annual total assets of Amer Bio Medica from 1996 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $1.27 Million | -32.61% |
| 2021-12-31 | $1.88 Million | -2.23% |
| 2020-12-31 | $1.93 Million | -7.31% |
| 2019-12-31 | $2.08 Million | -16.04% |
| 2018-12-31 | $2.48 Million | -14.39% |
| 2017-12-31 | $2.89 Million | -14.24% |
| 2016-12-31 | $3.37 Million | -11.22% |
| 2015-12-31 | $3.80 Million | -6.89% |
| 2014-12-31 | $4.08 Million | -17.88% |
| 2013-12-31 | $4.97 Million | +3.91% |
| 2012-12-31 | $4.78 Million | -15.21% |
| 2011-12-31 | $5.64 Million | -6.30% |
| 2010-12-31 | $6.01 Million | -14.56% |
| 2009-12-31 | $7.04 Million | -22.94% |
| 2008-12-31 | $9.14 Million | -0.15% |
| 2007-12-31 | $9.15 Million | +1.47% |
| 2006-12-31 | $9.02 Million | +13.59% |
| 2005-12-31 | $7.94 Million | -5.22% |
| 2004-12-31 | $8.38 Million | +23.56% |
| 2003-12-31 | $6.78 Million | +20.01% |
| 2002-12-31 | $5.65 Million | +11.05% |
| 2001-12-31 | $5.09 Million | +0.95% |
| 2000-12-31 | $5.04 Million | +13.60% |
| 1999-12-31 | $4.43 Million | -17.87% |
| 1998-12-31 | $5.40 Million | +31.49% |
| 1997-12-31 | $4.11 Million | 0.00% |
| 1996-12-31 | $4.11 Million | -- |